Analysis

Prime Medicine, Inc. (PRME) Stock Analysis

Prime Medicine, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to PRME.

websitePRME/analysis/PRME

Prime Medicine, Inc.

Prime Medicine, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to PRME.

Stock profile

Ticker

PRME

Asset type

Stock

Market cap

$583.4M

Sector

Health Technology

Industry

Biotechnology

Currency

USD

Ticker listings

Prime Medicine, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • PRME primary listing

Latest Prime Medicine, Inc. news

Prime Medicine to Present at Goldman Sachs 47th Annual Global Healthcare Conference

CAMBRIDGE, Mass., June 03, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time c...

Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates

-- On track to file IND and/or CTA for PM577 in Wilson Disease in H1 2026 and for PM647 in AATD mid-2026; initial clinical data from both programs expected in 2027 -- -- Continu...

Prime Medicine Appoints Svetlana Makhni as Chief Financial Officer

CAMBRIDGE, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time ...

Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates

-- On track to file IND and/or CTA for Wilson Disease and AATD programs in 1H 2026 and mid-2026, respectively; initial clinical data for both expected in 2027 -- -- Ongoing enga...

Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time c...

Research sections

Valuation

Review valuation context for Prime Medicine, Inc..

Future growth

Review future growth context for Prime Medicine, Inc..

Past performance

Review past performance context for Prime Medicine, Inc..

Financial health

Review financial health context for Prime Medicine, Inc..

Dividend

Review dividend context for Prime Medicine, Inc..

Management

Review management context for Prime Medicine, Inc..

Ownership

Review ownership context for Prime Medicine, Inc..

Other information

Review other information context for Prime Medicine, Inc..

Community

Review community context for Prime Medicine, Inc..